| 1. |
Charles F, Thomas Jr, Andrew H.Pneumocystis pneumonia.N Engl J Med, 2004, 351:2487-2499.
|
| 2. |
Sunkin SM, Stringer JR.Translocation of surface antigen genes to a unique telomeric expression site in Pneumocystis carina.Mol Microbiol, 1996, 19:283-295.
|
| 3. |
Morris A, Norris KA.Colonization by Pneumocystis jirovecii and its role in disease.Clin Microbiol Rev, 2012, 25:297-317.
|
| 4. |
Huggett JF, Taylor MS, Kocjan G, et al.Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients.Thorax, 2008, 63:154-159.
|
| 5. |
Shimizu Y, Sunaga N, Dobash K, et al.Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization:a prospective study.BMC Infect Dis, 2009, 9:47.
|
| 6. |
Damiani C, Gal SL, Lejeune D, et al.Serum (1→3)-β-D-glucan levels in primary infection and pulmonary colonization with Pneumocystis jirovecii.J Clin Microbiol, 2011, 49:2000-2002.
|
| 7. |
Damiani C, Gal SL, Costa CD, et al.Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1→3)-β-D-glucan for differential diagnosis of Pneumocystis pneumonia and Pneumocystis colonization.J Clin Microbiol, 2013, 51:3380-3388.
|
| 8. |
Matsumura Y, Ito Y, Linuma Y, et al.Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization.Clin Microbiol Infect, 2012, 18:591-597.
|
| 9. |
Nevez G, Raccurt C, Vincent P, et al.Pulmonary colonization with Pneumocystis carina in human immunodeficiency virus-negative patients:assessing risk with blood CD4+ T cell counts.Clin Infect Dis, 1999, 29:1331-1332.
|
| 10. |
Medrano FJ, Montes-Cano M, Conde M, et al.Pneumocystis jirovecii in general population.Merg Infect Dis, 2005, 11:245-250.
|
| 11. |
An CL, Gigliotti F, Harmsen AG.Exposure of immunocompetent adult mice to Pneumocystis carina f.sp.muris by cohousing:growth of P.carinii f.sp.muris and host immune response.Infect Immun, 2003, 71:2065-2070.
|
| 12. |
Gigliotti F, Harmsen AG, Wright TW.Characterization of transmission of Pneumocystis carina f.sp.muris through immunocompetent BALB/c mice.Infect Immun, 2003, 71:3852-3856.
|
| 13. |
Togashi Y, Masago K, Ito Y, et al.Pneumocystis jiroveci pneumonia and colonization in patients with advanced lung cancer.Oncol Lett, 2013, 5:601-604.
|
| 14. |
Vidal S, De la Horra C, Martin J, et al.Pneumocystis jirovecii colonisation in patients with interstitial lung disease.Clin Microbiol Infect, 2006, 12:231-235.
|
| 15. |
Mori S, Cho I, Sugimoto M.A follow-up of asymptomatic carriers of Pneumocystis jirovecii during immunosuppressive therapy of rheumatoid arthritis.J Rheumatol, 2009, 36:8.
|
| 16. |
Wang DD, Zheng MQ, Zhang N, et al.Investigation of Pneumocystis jirovecii colonization in patients with chronic pulmonary diseases in the People's Republic of China.Int J COPD, 2015, 10:2079-2085.
|
| 17. |
Morris A, Sciurba FC, Lebedeva IP, et al.Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization.Am J Respir Crit Care Med, 2004, 170:408-413.
|
| 18. |
Calderon EJ, Rivero L, Respaldiza N, et al.Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci.Clin Infect Dis, 2007, 45:e17-e19.
|
| 19. |
Sethi S.Bacterial infection and the pathogenesis of COPD.Chest, 2000, 117:286S-291S.
|
| 20. |
Lebron F, Vassallo R, Puri V, et al.Pneumocystis carina cell wall β-glucans initiate macrophage inflammatory responses through NF-κB activation.J Biol Chem, 2003, 278:25001-25008.
|
| 21. |
Morris A, Sciurba FC, Norris KA, et al.Pneumocystis:a novel pathogen in chronic obstructive pulmonary disease? COPD, 2008, 5:43-51.
|
| 22. |
Morris A, Alexander T, Radhi S, et al.Airway obstruction is increased in Pneumocystis-colonized human immunodeficiency virus-infected outpatients.J Clin Microbiol, 2009, 47:3773-3776.
|
| 23. |
du Bois RM, Goh N, McGrath D, et al.Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Intern Med, 2003, 253:4-17.
|
| 24. |
Martin-Juan J, Gomez-Izquierdo L, Lara L, et al.Pneumocystis jirovecii en pacientes con enfermedad pulmonar intersticial difusa.Neumosur, 2008, 20:65-73.
|
| 25. |
Maskell NA, Waine DJ, Lindley A, et al.Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy:a prospective study.Thorax, 2003, 58:594-597.
|
| 26. |
De la Horra C, Varela JM, Fernandez-Alonso J, et al.Association between human-Pneumocystis infection and small-cell lung carcinoma.Eur J Clin Invest, 2004, 34:229-235.
|
| 27. |
Msaad S, Yangui I, Bahloul N, et al.Do inhaled corticosteroids increase the risk of Pneumocystis pneumonia in people with lung cancer? World J Clin Cases, 2015, 3:843-847.
|
| 28. |
Tsai SH, Lin YY, Wu YC, et al.Pulmonary opportunistic infections in a lung cancer patient treated by inhaled corticosteroid.J Intern Med Taiwan, 2009, 20:92-96.
|
| 29. |
Helweg-Larsen J, Jensen JS, Dohn B, et al.Detection of Pneumocystis DNA in samples from patients suspected of bacterial pneumonia——a case-control study.BMC Infect Dis, 2002, 2:28.
|
| 30. |
Mekinian A, Durand-Joly I, Hatron PY, et al.Pneumocystis jirovecii colonization in patients with systemic autoimmune diseases:prevalence, risk factors of colonization and outcome.Rheumatology, 2011, 50:569-577.
|
| 31. |
Deterding RR, Schimizu H, Fisher JH, et al.Regulation of surfactant protein D expression by glucocorticoids in vitro and in vivo.Am J Respir Cell Mol Biol, 1994, 10:30-37.
|
| 32. |
Guo Z, Kaneshiro ES.Phospholipid composition of Pneumocystis carina carina and effects of methylprednisolone immunosuppression on rat lung lipids.Infect Immun, 1995, 63:1286-1290.
|
| 33. |
Aliouat EM, Escamilla R, Cariven C, et al.Surfactant changes during experimental pneumocystosis are related to Pneumocystis development.Eur Respir J, 1998, 11:542-547.
|
1/5
WeChat